Press Releases
Combating the Corona Virus with Regensburg High-Tech
(No. 246) The company 2bind GmbH, located at BioPark Regensburg, is part of a research project at the location which has the goal of developing an active substance to combat COVID-19.
read on
Green Energy from Aquaculture Discharge using Biotechnology
(No. 245) Hyperthermics Regensburg GmbH is researching the use of heat-stable organisms to be able to use these to aquire energy. The norwegian mother company has now succeeded for the first time to use mud occuring in fish farming sustainably for green energy.
read on
relyon plasma receives Licence for Medical Products
(No. 244b) The Regensburg medical engineering company relyon plasma GmbH has successfully completed certification for its quality management of medical products. The company develops innovative plasma systems for disinfection and with this step it has enriched the location as a further manufacturer of medical products.
read on
Mikrogen Diagnostics acquires Lophius Biosciences
(No. 244a) The diagnostic company Mikrogen GmbH from Neuried is acquiring Lophius Biosciences GmbH from BioPark Regensburg to enter the future market of T-cell based tests. Immunodiagnostics plays a huge role in the fields of transplantation as well as infectious diseases and autoimmune disease.
read on
Current BioPark Financial Report 2020
(No. 243) The current development of the life science companies in the Regensburg BioRegion demonstrates a slight increase in the number of companies and employees in East Bavaria despite the Corona crisis. The new financial figures for 2020 presented by BioPark Regensburg GmbH amount to 61 companies and 4,093 employees for the cluster in East Bavaria.
read onARCHIVE
